Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant

NCT02464878 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

2

Enrollment

OTHER

Sponsor class

Conditions

Kidney Transplant
Type 1 Diabetes

Interventions

DRUG: Alpha 1-Antitrypsin
PROCEDURE: Islet Transplantation
DRUG: Thymoglobulin
DRUG: Basiliximab
DRUG: Etanercept

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]